drugset / Trial / NCT01958866
Study of Efficacy and Safety of Tinospora Crispa-extract Product Compared With the Acetaminophen
RandomizedParallel-groupTriple-blindTreatment
Summary
Hypothesis: Tinospora Crispa-extract Product can reduce pyretic similar to acetaminophen. This study aims to investigate the efficacy and safety of Tinospora Crispa-extract product compared with the acetaminophen. Total of 96 patients with body temperature between 37.8-38.5 without any signs of infections will be enrolled in this study. Patients will be randomly divided into 3 groups: First group will receive acetaminophen 1000 mg every 6 hr, Second group will receive Tinospora Crispa-extract Product 2000 mg twice daily and the third group will receive placebo twice daily.
Timeline
- Start
- 2013-10
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 1000 mg | — |
| Subject | Tinospora Crispa-extract Product | Unknown | 500 mg | — |
| Subject | Tinospora Crispa-extract Product | Unknown | 2000 mg | — |
Indications
No indication recorded.